PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT
May 1, 2009, 00:00
10.1016/S1098-3015(10)73350-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)73350-7/fulltext
Title :
PGI3 RISK OF UPPER GASTROINTESTINAL ADVERSE EVENTS AND THE EFFECT OF ACID-SUPPRESSIVE THERAPY IN PATIENTS RECEIVING ACETYLSALICYLIC ACID FOR CARDIOVASCULAR RISK MANAGEMENT
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73350-7&doi=10.1016/S1098-3015(10)73350-7
First page :
Section Title :
Open access? :
No
Section Order :
778